CVE-2026-54449: LangBot · Command Injection
Affects LangBotSource CVE Database V5
Not known to be exploited · CVSS 8.8 High.
Data as of 26 Oct 2026, 17:16 UTC
- EPSS
- 0.7% chance of exploitation in 30 days – higher than 53% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- CISA SSVC
- Exploitation
- No evidence of active exploitation and no public proof of concept
- Automatable
- Attackers cannot reliably automate steps 1–4 of the kill chain
- Technical impact
- Total control over the software or total information disclosure
CISA SSVC assessment, 2026-08-21.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 20 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| langbot-appLangBot | Affected
| Fixed in– |
Description
LangBot is a global IM bot platform designed for LLMs. In version 4.10.7 and earlier, any authenticated user can add or change an STDIO MCP server configuration without an adequate authorization boundary. In src/langbot/pkg/provider/tools/loaders/mcp.py, StdioServerParameters accepts the configured command and arguments and starts a server-side subprocess on the LangBot server. An attacker who can sign up or obtain an account can use the Extensions MCP configuration to execute arbitrary commands with the privileges of the LangBot service, enabling data disclosure, modification, and service disruption. No fixed version is available as of this review.